{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:02:08Z","timestamp":1744736528946},"reference-count":10,"publisher":"Medical Association of Nippon Medical School","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1272\/jnms.84.177","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T22:32:25Z","timestamp":1507156345000},"page":"177-182","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Drug Monitoring Simulator for Antibiotic Dosage for Methicillin-Resistant &lt;i&gt;Staphylococcus aureus&lt;\/i&gt; Sepsis in a Patient with Primary Immunodeficiency on Peritoneal Dialysis"],"prefix":"10.1272","volume":"84","author":[{"given":"Hidehiko","family":"Narazaki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohiko","family":"Kaizu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyo","family":"Jitsukawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nippon Medical School, Chiba Hokuso Hospital"},{"name":"Division of Infection Control and Prevention, Nippon Medical School, Chiba Hokusoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. Ochs HD: The Wiskott-Aldrich syndrome. Semin Hematol 1998; 35: 332-345."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liu CH, Wu KH, Lin TY, Wei CC, Lin CY, Chen XX, Lee WI: Wiskott-Aldrich syndrome with IgA nephropathy: a case report and literature review. Int Urol Nephrol 2013; 45: 1495-1500.","DOI":"10.1007\/s11255-012-0178-0"},{"key":"3","unstructured":"3. The POC-IT Center of The Johns Hopkins University: The Johns Hopkins POC-IT ABX Guide."},{"key":"4","unstructured":"4. Japanese Society of Chemotherapy: The antibiotics TDM guideline. Nihon Kagakuryouhou Gakkai Zasshi 2012; 60: 393-445."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Higuchi S, Aoyama T, Horioka M: PEDA: a microcomputer program for parameter estimation and dosage adjustment in clinical practice. J Pharmacobiodyn 1987; 10: 703-718.","DOI":"10.1248\/bpb1978.10.703"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shea KW, Cunha BA: Teicoplanin. Med Clin North Am 1995; 79: 833-844.","DOI":"10.1016\/S0025-7125(16)30042-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Derbyshire N, Webb DB, Roberts D, Glew D, Williams JD: Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function. J Antimicrob Chemother 1989; 23: 869-876.","DOI":"10.1093\/jac\/23.6.869"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stamatiadis D, Papaioannou MG, Giamarellos-Bourboulis EJ, Marinaki S, Giamarellou H, Stathakis CP: Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 2003; 23: 127-131.","DOI":"10.1177\/089686080302300206"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Guay DR, Awni WM, Halstenson CE, Kenny MT, Keane WF, Matzke GR: Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing. Antimicrob Agents Chemother 1989; 33: 2012-2015.","DOI":"10.1128\/AAC.33.11.2012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamamoto T, Yasuno N, Katada S, Hisaka A, Hanafusa N, Noiri E, Yahagi N, Fujita T, Suzuki H: Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration. Antimicrob Agents Chemother 2011; 55: 5804-5812.","DOI":"10.1128\/AAC.01758-10"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/84\/4\/84_177\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T19:02:01Z","timestamp":1603047721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/84\/4\/84_177\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.84.177","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}